Switch theme
Sign up to access all valuation multiples
Carmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable orthotopic and biocompatible artificial heart organs for the treatment of heart failure patients. The company also develops the product's power supply system and its control and remote diagnosis systems.
2008
179
LTM Revenue $9.9M
LTM EBITDA -$45.8M
$105M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Carmat has a last 12-month revenue of $9.9M and a last 12-month EBITDA of -$45.8M.
In the most recent fiscal year, Carmat achieved revenue of $3.1M and an EBITDA of -$49.7M.
Carmat expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Carmat valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $3.1M | $7.5M | XXX | XXX | XXX |
| Gross Profit | -$43.5M | -$30.6M | XXX | XXX | XXX |
| Gross Margin | -1422% | -406% | XXX | XXX | XXX |
| EBITDA | -$49.7M | -$47.2M | XXX | XXX | XXX |
| EBITDA Margin | -1624% | -627% | XXX | XXX | XXX |
| Net Profit | -$66.5M | -$57.7M | XXX | XXX | XXX |
| Net Margin | -2173% | -767% | XXX | XXX | XXX |
| Net Debt | $13.8M | $4.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Carmat's stock price is EUR 1 (or $1).
Carmat has current market cap of EUR 50.8M (or $54.6M), and EV of EUR 97.9M (or $105M).
See Carmat trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $105M | $54.6M | XXX | XXX | XXX | XXX | $-1.11 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Carmat has market cap of $54.6M and EV of $105M.
Carmat's trades at 10.6x LTM EV/Revenue multiple, and -2.3x LTM EBITDA.
Analysts estimate Carmat's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Carmat and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $105M | XXX | XXX | XXX |
| EV/Revenue | 14.0x | XXX | XXX | XXX |
| EV/EBITDA | -2.2x | XXX | XXX | XXX |
| P/E | -1.1x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -1.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCarmat's NTM/LTM revenue growth is 146%
Carmat's revenue per employee for the last fiscal year averaged $17K, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Carmat's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Carmat's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Carmat and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 146% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -627% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -5% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -482% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $17K | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 351% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carmat acquired XXX companies to date.
Last acquisition by Carmat was XXXXXXXX, XXXXX XXXXX XXXXXX . Carmat acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Carmat founded? | Carmat was founded in 2008. |
| Where is Carmat headquartered? | Carmat is headquartered in France. |
| How many employees does Carmat have? | As of today, Carmat has 179 employees. |
| Who is the CEO of Carmat? | Carmat's CEO is Mr. Stephane Piat. |
| Is Carmat publicy listed? | Yes, Carmat is a public company listed on PAR. |
| What is the stock symbol of Carmat? | Carmat trades under ALCAR ticker. |
| When did Carmat go public? | Carmat went public in 2010. |
| Who are competitors of Carmat? | Similar companies to Carmat include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Carmat? | Carmat's current market cap is $54.6M |
| What is the current revenue of Carmat? | Carmat's last 12-month revenue is $9.9M. |
| What is the current EBITDA of Carmat? | Carmat's last 12-month EBITDA is -$45.8M. |
| What is the current EV/Revenue multiple of Carmat? | Current revenue multiple of Carmat is 10.6x. |
| What is the current EV/EBITDA multiple of Carmat? | Current EBITDA multiple of Carmat is -2.3x. |
| What is the current revenue growth of Carmat? | Carmat revenue growth between 2023 and 2024 was 146%. |
| Is Carmat profitable? | Yes, Carmat is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
